Gould Robert J
CIK 0001577034
Interim President & CEODirector
Filings
14
Latest Feb 4, 2026
Issuers covered
2
Showing
14 of 14
Page 1
Track record
13 of 13 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 13 | 92% | +30.0% | +27.2% | +66.5% | -6.7% |
| 90 days | 13 | 92% | +38.0% | +26.4% | +81.7% | -2.8% |
| 180 days | 10 | 100% | +44.0% | +55.3% | +72.9% | +12.9% |
| 365 days | 9 | 100% | +71.3% | +61.5% | +89.9% | +45.3% |
Issuers
Companies where Gould Robert J has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| FULC | Fulcrum Therapeutics, Inc. | 13 | Feb 4, 2026 |
| TSBX | Turnstone Biologics Corp. | 1 | Jul 2, 2024 |
All filings
14 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|